Literature DB >> 19415417

Alterations in the cerebral venous circulation as a cause of headache.

Elio Agostoni1, Angelo Aliprandi.   

Abstract

The alterations of the cerebral venous circulation are a rare but clinically important cause of headache. Although any process involving the cerebral veins or sinuses may cause headache, the most frequent and important are cerebral venous thrombosis and idiopathic intracranial hypertension. The headache of cerebral venous thrombosis does not have specific features and may be isolated; therefore, all patients with headache and risk factors for venous thrombosis should undergo the appropriate neuroradiologic examinations to rule out the diagnosis. In fact, early anticoagulant treatment may dramatically change the clinical outcome. Also idiopathic intracranial hypertension, if untreated, may have serious clinical consequences such as permanent visual loss. The pathogenesis of this disorder has not been clearly established and several possibilities involving the cerebral circulation are discussed.

Entities:  

Mesh:

Year:  2009        PMID: 19415417     DOI: 10.1007/s10072-009-0052-8

Source DB:  PubMed          Journal:  Neurol Sci        ISSN: 1590-1874            Impact factor:   3.307


  25 in total

Review 1.  Cerebral venous thrombosis: an update.

Authors:  Marie-Germaine Bousser; José M Ferro
Journal:  Lancet Neurol       Date:  2007-02       Impact factor: 44.182

2.  Cerebral venous sinus thrombosis presenting as subdural haematoma.

Authors:  S Singh; S Kumar; M Joseph; C Gnanamuthu; M Alexander
Journal:  Australas Radiol       Date:  2005-04

3.  Migraine-like visual phenomena associated with cerebral venous thrombosis.

Authors:  D S Newman; S R Levine; V L Curtis; K M Welch
Journal:  Headache       Date:  1989-02       Impact factor: 5.887

4.  Prognosis of cerebral vein and dural sinus thrombosis: results of the International Study on Cerebral Vein and Dural Sinus Thrombosis (ISCVT).

Authors:  José M Ferro; Patrícia Canhão; Jan Stam; Marie-Germaine Bousser; Fernando Barinagarrementeria
Journal:  Stroke       Date:  2004-02-19       Impact factor: 7.914

Review 5.  Cerebral venous infarction: the pathophysiological concept.

Authors:  B Schaller; R Graf
Journal:  Cerebrovasc Dis       Date:  2004-07-22       Impact factor: 2.762

6.  Diffusion-weighted magnetic resonance imaging in a case of cerebral venous thrombosis.

Authors:  J C Corvol; C Oppenheim; R Manaï; M Logak; D Dormont; Y Samson; C Marsault; G Rancurel
Journal:  Stroke       Date:  1998-12       Impact factor: 7.914

7.  Diffusion-weighted magnetic resonance imaging of dural sinus thrombosis.

Authors:  T Yoshikawa; O Abe; K Tsuchiya; T Okubo; K Tobe; T Masumoto; N Hayashi; H Mori; H Yamada; S Aoki; K Ohtomo
Journal:  Neuroradiology       Date:  2002-04-25       Impact factor: 2.804

8.  Sudden onset headache: a prospective study of features, incidence and causes.

Authors:  A-M Landtblom; S Fridriksson; J Boivie; J Hillman; G Johansson; I Johansson
Journal:  Cephalalgia       Date:  2002-06       Impact factor: 6.292

9.  The incidence of pseudotumor cerebri. Population studies in Iowa and Louisiana.

Authors:  F J Durcan; J J Corbett; M Wall
Journal:  Arch Neurol       Date:  1988-08

10.  Epidemiology of idiopathic intracranial hypertension: a prospective and case-control study.

Authors:  K Radhakrishnan; A K Thacker; N H Bohlaga; J C Maloo; S E Gerryo
Journal:  J Neurol Sci       Date:  1993-05       Impact factor: 3.181

View more
  2 in total

1.  Headache in cerebral venous thrombosis associated with extracranial tumors: a clinical series.

Authors:  S Iurlaro; A Silvani; M Mauri; G Truci; S Beretta; A Zilioli; M Guidotti; A Salmaggi; C Ferrarese; G Comi; M Riva
Journal:  Neurol Sci       Date:  2015-05       Impact factor: 3.307

2.  Paradoxical presentation of orthostatic headache associated with increased intracranial pressure in patients with cerebral venous thrombosis.

Authors:  Jung B Kim; Do-Young Kwon; Moon-Ho Park; Byung-Jo Kim; Kun-Woo Park
Journal:  Ann Indian Acad Neurol       Date:  2013-01       Impact factor: 1.383

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.